BriaCell Therapeutics Corp. (BCTX) Other Operating Expenses (2021 - 2022)
BriaCell Therapeutics (BCTX) posted Other Operating Expenses of -$34400.0 for Q2 2022, down 33.33% sequentially from -$25800.0 in Q1 2022, and down 704.11% YoY from $5694.3 in Q2 2021.
BriaCell Therapeutics Corp. (BCTX) Other Operating Expenses (2021 - 2022) Analysis & Trends
BriaCell Therapeutics has reported Other Operating Expenses for 2 years, with the latest figure at -$34400.0 in Q2 2022.
- Quarterly Other Operating Expenses fell 704.11% year-over-year to -$34400.0 in Q2 2022, while the trailing twelve-month figure through Jan 2023 was -$34400.0 (up 16.54% YoY) and the FY2021 annual result came in at -$30568.0, changed N/A from the prior year.
- Other Operating Expenses slipped to -$34400.0 in Q2 2022 per BCTX's latest filing, from -$25800.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at -$4278.0 in Q2 2021 and troughed at -$34400.0 in Q2 2022.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2022 | -34,400.00 |
| Jan 31, 2022 | -25,800.00 |
| Jul 31, 2021 | -11,137.00 |
| Apr 30, 2021 | -4,278.00 |
| Jan 31, 2021 | -7,710.00 |